ARS Pharma Launches Neffy Access Program for Allergy Patients
November 4, 2025
ARS Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to better protect themselves from allergic reactions that could lead